Summary
Mayne Pharma Group Ltd. (MYX) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Mayne Pharma Group Ltd. ever had a stock split?
Mayne Pharma Group Ltd. Profile
| Pharmaceuticals Industry | Healthcare Sector | Mr. Shawn Patrick O'Brien B.Sc CEO | ASX Exchange | Q5857C108 CUSIP |
| Australia Country | 491 Employees | - Last Dividend | 17 Jan 2023 Last Split | 29 Jun 2007 IPO Date |
Overview
Mayne Pharma Group Limited is a specialty pharmaceutical company dedicated to the manufacturing and sale of both branded and generic pharmaceutical products. Its operations span across a wide geographical reach including Australia, New Zealand, the United States, Canada, Europe, Asia, and beyond. The company operates through four primary segments: International Branded Products, and Portfolio Product Division, offering a diverse range of pharmaceutical solutions. Originally established as Halcygen Pharmaceuticals Limited, it rebranded to Mayne Pharma Group Limited in November 2010. Since its incorporation in 2005, the company has been headquartered in Salisbury South, Australia, maintaining its commitment to advancing healthcare through innovative pharmaceutical solutions.
Products and Services
Mayne Pharma Group Limited offers a comprehensive range of products and services designed to meet the diverse needs of the healthcare industry:
- Oral Drug Delivery Systems: Specializing in sophisticated drug delivery methods, Mayne Pharma develops oral dosing solutions aimed at improving the efficacy and patient experience of pharmaceuticals. This includes a focus on enhancing the bioavailability of medications, ensuring that patients receive effective and reliable treatment options.
- Contract Development and Manufacturing Services: Mayne Pharma extends its expertise to third-party customers through contract services that encompass the development and manufacturing of pharmaceutical products. This offering allows other pharmaceutical companies to leverage Mayne Pharma’s advanced facilities and expertise to bring their products to market efficiently and with high quality.
- Distribution of Specialty Pharmaceutical Products: The company is also active in the distribution of specialized pharmaceutical products, with a focus on therapeutic areas such as dermatology, women's health, and infectious diseases. By providing access to these critical medicines, Mayne Pharma aims to address unmet medical needs and contribute to healthier communities.
